- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 3.89M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 3.89M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 3.89M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $75.23K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$153.24K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$3.15M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$3.21M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$2.26M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$2.17M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.05M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $4.08M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $4.05M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.08M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $327.17K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $306.52K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $904.55K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $868.76K |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.01 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.01 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $169.53K |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $146.74K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $20.06K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $29.75K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$27.25K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$92.77K |
| Operating Income | Q1 2026 · Mar 31, 2026 | $40.25K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$177.62K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $193.71K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $69.02K |